The Second Affiliated Hospital Of Chongqing Medical University

This study tests whether combining two drugs—ASC22 and pegylated interferon alfa—can functionally cure chronic hepatitis B. It involves 150 adults with low virus levels and no hepatitis B e-antigen. The goal is to raise the cure rate above 50% without needing to select specific p…

This study tests a new combination of drugs to achieve a functional cure for chronic hepatitis B, meaning the virus is controlled without lifelong medication. About 120 adults with chronic hepatitis B will receive an immune-boosting drug (anti-PD-1 antibody) along with standard a…

This study tests a new way to place a stent (a small tube) in the liver to treat serious complications of cirrhosis, like bleeding or fluid buildup. The new technique uses a smaller balloon to keep the stent slightly narrow at first, which may lower the risk of a brain condition …

This study tests a new combination of drugs (anti-PD-1 antibody and interferon) to help the immune system clear the hepatitis B virus from the body. The goal is to achieve a 'functional cure,' meaning the virus is no longer active and the patient can stop long-term medication. Ab…

This study tests a new way to give radiation for lung cancer. Doctors will use a special scan to see which parts of the lung are working best, then aim the radiation away from those areas. The goal is to reduce lung damage and side effects like breathing problems. About 100 adult…